Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > CSF1R(Gene name) > Human
  • Add your favorite
  • CSF1R (Gene name),
  • Macrophage colony-stimulating factor 1 receptor (Protein name ),  CSF1R_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    CSF1R(FMS);
    Protein name:
    Macrophage colony-stimulating factor 1 receptor(CSF-1-R);
    Alternative:
    Proto-oncogene c-Fms;2.7.10.1;Proto-oncogene c-Fms(CSF-1-R);
    CD:
    CD115;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Interacts with INPPL1/SHIP2 and THOC5.
    Function:
    Protein tyrosine-kinase transmembrane receptor for CSF1 and IL34.
    Subcellular Location:
    Membrane Single-pass type I membrane protein
    Protein Attributes:
    Sequence length:
    972
    Sequence:
    50:
    MGPGVLLLLL | VATAWHGQGI | PVIEPSVPEL | VVKPGATVTL | RCVGNGSVEW | 
    100:
    DGPPSPHWTL | YSDGSSSILS | TNNATFQNTG | TYRCTEPGDP | LGGSAAIHLY | 
    150:
    VKDPARPWNV | LAQEVVVFED | QDALLPCLLT | DPVLEAGVSL | VRVRGRPLMR | 
    200:
    HTNYSFSPWH | GFTIHRAKFI | QSQDYQCSAL | MGGRKVMSIS | IRLKVQKVIP | 
    250:
    GPPALTLVPA | ELVRIRGEAA | QIVCSASSVD | VNFDVFLQHN | NTKLAIPQQS | 
    300:
    DFHNNRYQKV | LTLNLDQVDF | QHAGNYSCVA | SNVQGKHSTS | MFFRVVESAY | 
    350:
    LNLSSEQNLI | QEVTVGEGLN | LKVMVEAYPG | LQGFNWTYLG | PFSDHQPEPK | 
    400:
    LANATTKDTY | RHTFTLSLPR | LKPSEAGRYS | FLARNPGGWR | ALTFELTLRY | 
    450:
    PPEVSVIWTF | INGSGTLLCA | ASGYPQPNVT | WLQCSGHTDR | CDEAQVLQVW | 
    500:
    DDPYPEVLSQ | EPFHKVTVQS | LLTVETLEHN | QTYECRAHNS | VGSGSWAFIP | 
    550:
    ISAGAHTHPP | DEFLFTPVVV | ACMSIMALLL | LLLLLLLYKY | KQKPKYQVRW | 
    600:
    KIIESYEGNS | YTFIDPTQLP | YNEKWEFPRN | NLQFGKTLGA | GAFGKVVEAT | 
    650:
    AFGLGKEDAV | LKVAVKMLKS | TAHADEKEAL | MSELKIMSHL | GQHENIVNLL | 
    700:
    GACTHGGPVL | VITEYCCYGD | LLNFLRRKAE | AMLGPSLSPG | QDPEGGVDYK | 
    750:
    NIHLEKKYVR | RDSGFSSQGV | DTYVEMRPVS | TSSNDSFSEQ | DLDKEDGRPL | 
    800:
    ELRDLLHFSS | QVAQGMAFLA | SKNCIHRDVA | ARNVLLTNGH | VAKIGDFGLA | 
    850:
    RDIMNDSNYI | VKGNARLPVK | WMAPESIFDC | VYTVQSDVWS | YGILLWEIFS | 
    900:
    LGLNPYPGIL | VNSKFYKLVK | DGYQMAQPAF | APKNIYSIMQ | ACWALEPTHR | 
    950:
    PTFQQICSFL | QEQAQEDRRE | RDYTNLPSSS | RSGGSGSSSS | ELEEESSSEH | 
    972:
    LTCCEQGDIA | QPLLQPNNYQ | FC
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    KEGG:
    SMR:
    MIM:
    UniGene:
    String:
    Pfam:
    Uniprot:
     
    FOR
    ELISA Kit for Human CSF-1-R
    Cat.:
    E1594h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human CSF-1-R
    Cat.:
    E1594m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    ELISA Kit for Human CSF-1-R
    Cat.:
    E1594r
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human CSF-1-R
    Cat.:
    U1594h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human CSF-1-R
    Cat.:
    U1594m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human CSF-1-R
    Cat.:
    U1594r
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Polyclonal Antibody for Human CSF-1-R
    Cat.:
    P1594Rb-h
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human CSF-1-R
    Cat.:
    P1594Rb-m
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human CSF-1-R
    Cat.:
    P1594Rb-r
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Monoclonal Antibody for Human CSF-1-R
    Monoclonal Antibody for Human CSF-1-R
    Monoclonal Antibody for Human CSF-1-R
    Protein for Human CSF-1-R
    Protein for Human CSF-1-R
    Protein for Human CSF-1-R

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "Nucleotide sequence and structural organization of the human FMS proto-oncogene."
      Hampe A. , Shamoon B.M. , Gobet M. , Sherr C.J. , Galibert F.
      Oncogene Res.4:9-17(1989) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]
    2. 2.
      "Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus."
      Coussens L. , van Beveren C. , Smith D. , Chen E. , Mitchell R.L. , Isacke C.M. , Verma I.M. , Ullrich A.
      Nature320:277-280(1986) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)
    3. 3.
      "Sequence analysis of two genomic regions containing the KIT and the FMS receptor tyrosine kinase genes."
      Andre C. , Hampe A. , Lachaume P. , Martin E. , Wang X.P. , Manus V. , Hu W.X. , Galibert F.
      Genomics39:216-226(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]
      tissue: Placenta.
    4. 4.
      "Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis."
      Jin P. , Zhang J. , Sumariwalla P.F. , Ni I. , Jorgensen B. , Crawford D. , Phillips S. , Feldmann M. , Shepard H.M. , Paleolog E.M.
      Arthritis Res. Ther.10:R73-R73(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)
    5. 6.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    6. 7.
      "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
      The MGC Project Team
      Genome Res.14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)
      tissue: Brain.
    7. 8.
      "Differential transcription of exon 1 of the human c-fms gene in placental trophoblasts and monocytes."
      Visvader J. , Verma I.M.
      Mol. Cell. Biol.9:1336-1341(1989) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-16
    8. 9.
      "The amino-terminal domain of the v-fms oncogene product includes a functional signal peptide that directs synthesis of a transforming glycoprotein in the absence of feline leukemia virus gag sequences."
      Wheeler E.F. , Roussel M.F. , Hampe A. , Walker M.H. , Fried V.A. , Look A.T. , Rettenmier C.W. , Sherr C.J.
      J. Virol.59:224-233(1986) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-16
    9. 10.
      "Expression of a novel exon in the 5' UTR of human c-fms transcripts."
      Flick M.B. , Sapi E. , Kacinski B.M.
      Submitted (1996-11) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-16
      tissue: Placenta.
    10. 11.
      "Expression of the human c-fms proto-oncogene in hematopoietic cells and its deletion in the 5q- syndrome."
      Nienhuis A.W. , Bunn H.F. , Turner P.H. , Gopal T.V. , Nash W.G. , O'Brien S.J. , Sherr C.J.
      Cell42:421-428(1985) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 244-295
    11. 12.
      "'Replacement' of COOH-terminal truncation of v-fms with c-fms sequences markedly reduces transformation potential."
      Browning P.J. , Bunn H.F. , Cline A. , Shuman M. , Nienhuis A.W.
      Proc. Natl. Acad. Sci. U.S.A.83:7800-7804(1986) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 874-972 (ISOFORM 1)
    12. 13.
      "Expression of human colony-stimulating factor-1 (CSF-1) receptor in murine pluripotent hematopoietic NFS-60 cells induces long-term proliferation in response to CSF-1 without loss of erythroid differentiation potential."
      Bourette R.P. , Mouchiroud G. , Ouazana R. , Morle F. , Godet J. , Blanchet J.P.
      Blood81:2511-2520(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN CELL PROLIFERATION
    13. 14.
      "Activation of Src family kinases by colony stimulating factor-1, and their association with its receptor."
      Courtneidge S.A. , Dhand R. , Pilat D. , Twamley G.M. , Waterfield M.D. , Roussel M.F.
      EMBO J.12:943-950(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH SRC; FYN AND YES1;MUTAGENESIS OF TYR-809
    14. 15.
      "Transcriptional regulation of the c-fms (CSF-1R) proto-oncogene in human breast carcinoma cells by glucocorticoids."
      Sapi E. , Flick M.B. , Gilmore-Hebert M. , Rodov S. , Kacinski B.M.
      Oncogene10:529-542(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INDUCTION BY GLUCOCORTICOIDS
    15. 16.
      "Cell specific transformation by c-fms activating loop mutations is attributable to constitutive receptor degradation."
      Morley G.M. , Uden M. , Gullick W.J. , Dibb N.J.
      Oncogene18:3076-3084(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: MUTAGENESIS OF TYR-708 AND ASP-802
    16. 17.
      "The inositol 5'-phosphatase SHIP-1 and the Src kinase Lyn negatively regulate macrophage colony-stimulating factor-induced Akt activity."
      Baran C.P. , Tridandapani S. , Helgason C.D. , Humphries R.K. , Krystal G. , Marsh C.B.
      J. Biol. Chem.278:38628-38636(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN CELLULAR SIGNALING; PHOSPHORYLATION OF INPP5D AND ACTIVATION OF AKT1
    17. 18.
      "Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture."
      Wrobel C.N. , Debnath J. , Lin E. , Beausoleil S. , Roussel M.F. , Brugge J.S.
      J. Cell Biol.165:263-273(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN REGULATION OF CELL PROLIFERATION; CELL ADHESION; CELL SHAPE AND INTEGRITY OF CELL JUNCTIONS;MUTAGENESIS OF LEU-301 AND TYR-969;ROLE IN DISEASE
    18. 19.
      "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry."
      Liu T. , Qian W.-J. , Gritsenko M.A. , Camp D.G. II , Monroe M.E. , Moore R.J. , Smith R.D.
      J. Proteome Res.4:2070-2080(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-302 AND ASN-353
      tissue: Plasma.
    19. 20.
      "Inhibition of phosphorylation of the colony-stimulating factor-1 receptor (c-Fms) tyrosine kinase in transfected cells by ABT-869 and other tyrosine kinase inhibitors."
      Guo J. , Marcotte P.A. , McCall J.O. , Dai Y. , Pease L.J. , Michaelides M.R. , Davidsen S.K. , Glaser K.B.
      Mol. Cancer Ther.5:1007-1013(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION AS CSF1 RECEPTOR;CATALYTIC ACTIVITY;AUTOPHOSPHORYLATION;ROLE IN DISEASE;ENZYME REGULATION
    20. 21.
      "A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model."
      Ohno H. , Kubo K. , Murooka H. , Kobayashi Y. , Nishitoba T. , Shibuya M. , Yoneda T. , Isoe T.
      Mol. Cancer Ther.5:2634-2643(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN CELL PROLIFERATION;CATALYTIC ACTIVITY;AUTOPHOSPHORYLATION;ROLE IN DISEASE;ENZYME REGULATION
    21. 22.
      "FMS receptor for M-CSF (CSF-1) is sensitive to the kinase inhibitor imatinib and mutation of Asp-802 to Val confers resistance."
      Taylor J.R. , Brownlow N. , Domin J. , Dibb N.J.
      Oncogene25:147-151(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN REGULATION OF CELL PROLIFERATION AND CELL SHAPE;CATALYTIC ACTIVITY;UBIQUITINATION;ENZYME REGULATION;MUTAGENESIS OF ASP-802
    22. 23.
      "Discovery of a cytokine and its receptor by functional screening of the extracellular proteome."
      Lin H. , Lee E. , Hestir K. , Leo C. , Huang M. , Bosch E. , Halenbeck R. , Wu G. , Zhou A. , Behrens D. , Hollenbaugh D. , Linnemann T. , Qin M. , Wong J. , Chu K. , Doberstein S.K. , Williams L.T.
      Science320:807-811(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION AS IL34 RECEPTOR
    23. 24.
      "Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals."
      Hiraga T. , Nakamura H.
      Int. J. Cancer124:215-222(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ROLE IN DISEASE;ENZYME REGULATION
    24. 25.
      "Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor."
      Patsialou A. , Wyckoff J. , Wang Y. , Goswami S. , Stanley E.R. , Condeelis J.S.
      Cancer Res.69:9498-9506(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ROLE IN DISEASE
    25. 26.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-699 AND SER-713;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    26. 27.
      "Colony stimulating factor-1 receptor as a target for small molecule inhibitors."
      Mashkani B. , Griffith R. , Ashman L.K.
      Bioorg. Med. Chem.18:1789-1797(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: AUTOPHOSPHORYLATION;ENZYME REGULATION
    27. 28.
      "IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation."
      Chihara T. , Suzu S. , Hassan R. , Chutiwitoonchai N. , Hiyoshi M. , Motoyoshi K. , Kimura F. , Okada S.
      Cell Death Differ.17:1917-1927(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION AS RECEPTOR FOR IL34 AND CSF1;PHOSPHORYLATION AT TYR-546; TYR-699; TYR-708; TYR-723 AND TYR-809;AUTOPHOSPHORYLATION;ENZYME REGULATION;INTERACTION WITH IL34 AND CSF1
    28. 29.
      "Macrophage-colony stimulating factor and interleukin-34 induce chemokines in human whole blood."
      Eda H. , Zhang J. , Keith R.H. , Michener M. , Beidler D.R. , Monahan J.B.
      Cytokine52:215-220(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION IN RELEASE OF PROINFLAMMATORY CHEMOKINES
    29. 30.
      "Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells."
      Wei S. , Nandi S. , Chitu V. , Yeung Y.G. , Yu W. , Huang M. , Williams L.T. , Lin H. , Stanley E.R.
      J. Leukoc. Biol.88:495-505(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION AS IL34 AND CSF1 RECEPTOR; ACTIVATION OF MAPK1/ERK2; MAPK3/ERK1; PHOSPHORYLATION AT TYR-723;AUTOPHOSPHORYLATION
    30. 31.
      "CSF-1 regulation of the wandering macrophage: complexity in action."
      Pixley F.J. , Stanley E.R.
      Trends Cell Biol.14:628-638(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON FUNCTION; SIGNALING PATHWAYS AND PHOSPHORYLATION
    31. 32.
      "Colony-stimulating factor-1 in immunity and inflammation."
      Chitu V. , Stanley E.R.
      Curr. Opin. Immunol.18:39-48(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON FUNCTION IN IMMUNITY AND INFLAMMATION;ROLE IN DISEASE
    32. 33.
      "Macrophage colony stimulating factor: not just for macrophages anymore! A gateway into complex biologies."
      Douglass T.G. , Driggers L. , Zhang J.G. , Hoa N. , Delgado C. , Williams C.C. , Dan Q. , Sanchez R. , Jeffes E.W. , Wepsic H.T. , Myers M.P. , Koths K. , Jadus M.R.
      Int. Immunopharmacol.8:1354-1376(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON FUNCTION; SIGNALING PATHWAYS AND PHOSPHORYLATION
    33. 34.
      "Blood monocytes: development, heterogeneity, and relationship with dendritic cells."
      Auffray C. , Sieweke M.H. , Geissmann F.
      Annu. Rev. Immunol.27:669-692(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW
    34. 35.
      "Crystal structure of the tyrosine kinase domain of colony-stimulating factor-1 receptor (cFMS) in complex with two inhibitors."
      Schubert C. , Schalk-Hihi C. , Struble G.T. , Ma H.C. , Petrounia I.P. , Brandt B. , Deckman I.C. , Patch R.J. , Player M.R. , Spurlino J.C. , Springer B.A.
      J. Biol. Chem.282:4094-4101(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 538-922 IN COMPLEXES WITH ARYLAMIDE AND QUINOLONE INHIBITORS;DOMAIN
    35. 36.
      "The 2.7 A crystal structure of the autoinhibited human c-Fms kinase domain."
      Walter M. , Lucet I.S. , Patel O. , Broughton S.E. , Bamert R. , Williams N.K. , Fantino E. , Wilks A.F. , Rossjohn J.
      J. Mol. Biol.367:839-847(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 543-918 IN AUTOINHIBITED CONFORMATION;DOMAIN
    36. 37.
      "Design and synthesis of a pyrido[2,3-d]pyrimidin-5-one class of anti-inflammatory FMS inhibitors."
      Huang H. , Hutta D.A. , Hu H. , DesJarlais R.L. , Schubert C. , Petrounia I.P. , Chaikin M.A. , Manthey C.L. , Player M.R.
      Bioorg. Med. Chem. Lett.18:2355-2361(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.02 ANGSTROMS) OF 538-922 IN COMPLEX WITH PYRIMIDINOPYRIDONE INHIBITOR;CATALYTIC ACTIVITY
    37. 38.
      "Pyrido[2,3-d]pyrimidin-5-ones: a novel class of antiinflammatory macrophage colony-stimulating factor-1 receptor inhibitors."
      Huang H. , Hutta D.A. , Rinker J.M. , Hu H. , Parsons W.H. , Schubert C. , DesJarlais R.L. , Crysler C.S. , Chaikin M.A. , Donatelli R.R. , Chen Y. , Cheng D. , Zhou Z. , Yurkow E. , Manthey C.L. , Player M.R.
      J. Med. Chem.52:1081-1099(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 538-922 IN COMPLEX WITH INHIBITOR;CATALYTIC ACTIVITY;FUNCTION IN INFLAMMATION AND DISEASE
    38. 39.
      "Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding mode."
      Meyers M.J. , Pelc M. , Kamtekar S. , Day J. , Poda G.I. , Hall M.K. , Michener M.L. , Reitz B.A. , Mathis K.J. , Pierce B.S. , Parikh M.D. , Mischke D.A. , Long S.A. , Parlow J.J. , Anderson D.R. , Thorarensen A.
      Bioorg. Med. Chem. Lett.20:1543-1547(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 538-922 IN COMPLEXES WITH INHIBITORS;CATALYTIC ACTIVITY;ENZYME REGULATION
    39. 41.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS HDLS 774-CYS--ASN-814 DEL; 585-GLY--LYS-619 DELINS ALA; GLU-589; LYS-633; THR-766; PRO-770; ASN-775; THR-794; TYR-837; SER-849; PHE-849 DEL; PRO-868; THR-875 AND THR-878;VARIANTS HIS-710; ARG-747 AND ASP-920;CHARACTERIZATION OF VARIANTS HDLS LYS-633; THR-766 AND THR-875
    Product Feedback Wall
    Hot Genes
    Top Searches
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter